PharmTech News

Articles

The medicine is the first outcome of the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19.

Eli Lilly Launches First Human Study of a Potential COVID-19 Antibody Treatment

The company announced that it has been issued a task order under a present contract with BARDA to use its contract development and manufacturing capabilities and knowledge to assist in the US government’s efforts to deliver COVID-19 vaccines.

Emergent Issued $628 Million Task Order from BARDA to Assist in US COVID-19 Vaccine Efforts

Merck will acquire Themis Bioscience and collaborate with IAVI and Ridgeback Bio on COVID-19 vaccines and therapies.

Merck Announces Acquisition, Collaborations for Developing COVID-19 Vaccines and Therapies

Funding from the US government could lead to 300 million coronavirus vaccine doses by October 2020.

BARDA Commits $1.2 Billion to AstraZeneca Vaccine Program

HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.

BARDA Funds US-based Drug Manufacturing Initiative

Participants in two dosing cohorts in Moderna’s mRNA-1273 study reached or exceeded neutralizing antibody titers generally seen in convalescent sera.

mRNA Vaccine Shows Positive Interim Phase I Results

Leadership was announced for the US government’s Operation Warp Speed program, which aims to deliver COVID-19 vaccines, therapeutics, and diagnostics. 

The US Government Moves Forward with Plans for Accelerating Manufacturing of COVID-19 Vaccines and Treatments

AbbVie and Allergan have satisfied all required antitrust clearances for the acquisition.

FTC Clears AbbVie’s $63-Billion Acquisition of Allergan

FDA’s EUA provides the first new treatment for COVID-19 patients with severe symptoms.

Remdesivir Approved for Emergency Use

NIH trial shows remdesivir accelerates recovery; Gilead study shows similar efficacy for 5- and 10-day dosing.

Top News